Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Plant Constituent with Selective Effect on Cancer Cells

No. 80 | 17/12/2007 | by (Koh)

The substance wogonin triggers the death program apoptosis in tumor cells, while it has virtually no effect on healthy cells. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have discovered the molecular mechanism underlying this selectivity.

Defects in genes that control growth can turn a cell into a threat for the whole organism. Defective cells that might get out of control are driven into suicide by a protective mechanism called apoptosis. However, this life saving mechanism is no longer working in most tumor cells, since numerous molecules regulating apoptosis are defective.

This is why researchers have been trying for some time to restore the capability of controlled suicide in tumor cells. However, this is a risky venture, because it involves the danger of damaging healthy tissue, too, by cell death. Therefore, scientists have urgently been searching for substances that induce cell death selectively in tumor cells.

Dr. Min Li-Weber of the Division of Immunogenetics headed by Prof. Dr. Peter Krammer has been concentrating on pure substances from herbs that are used in traditional Chinese medicine. Investigating their ability to trigger apoptosis, the scientist has recently come across an interesting candidate: the substance wogonin, a plant flavone from Baikal skullcap. Wogonin causes apoptosis in leukemia cells in the culture dish, while it has virtually no damaging effect on healthy blood cells. Wogonin also led to reduced cancer growth in mice that had been transplanted human leukemia cells.

The mechanism underlying the selective effect of this plant constituent had still been unclear. There are two different ways by which the apoptosis program can be started in a cell: by external stimuli or by signals from within the cell as a response to factors such as radioactive radiation or reactive oxygen compounds such as hydrogen peroxide (H2O2). Li-Weber has now shown that wogonin leads to highly increased formation of hydrogen peroxide in tumor cells compared to healthy cells. The peroxide, in turn, produces a calcium response which triggers the apoptosis reaction cascade. In addition, tumor cells contain a higher number of those membrane channels through which calcium flows from its intracellular storages into the cytoplasm.

Min Li-Weber's results so far are based on experiments in the culture dish and in the animal model. The scientists rate the data as convincing enough to continue testing the suitability of wogonin as a therapeutic agent for leukemias.

Sven Baumann, Stefanie C. Fas, Marco Giaisi, Wolfgang W. Müller, Anette Merling, Karsten Gülow, Lutz Edler, Peter H. Krammer and Min Li-Weber: Wogonin Preferentially Kills Malignant Lymphocytes and Suppresses T-cell Tumor Growth by Inducing PLCγ1- and Ca2+-dependent Apoptosis.
Blood, DOI: 10.1182/blood-2007-06-096198

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS